• Funding: EU Horizon 2020. 2016-01-01—2020-12-31.
  • Personnel: Neil Oxtoby, Marco Lorenzi, Sara Garbarino, Leon Aksman, Andre Altmann, Olga Ciccarelli, Sebastien Ourselin, Jonathan Schott, Daniel Alexander (PI).
  • Summary: The EuroPOND consortium is developing a data-driven statistical and computational modelling framework for neurological disease progression. This will enable major advances in differential and personalized diagnosis, prognosis, monitoring, and treatment and care decisions, positioning Europe as world leaders in one of the biggest societal challenges of 21st century healthcare. This work extends and augments ideas developed in the NeuroProgression project, as well as expanding the remit to include other neurological conditions such as multiple sclerosis, prion diseases, and encephalopathy of prematurity.

For further details, see the project homepage.